These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26137558)

  • 1. Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages?
    Golparian D; Unemo M
    EBioMedicine; 2015 Mar; 2(3):186-7. PubMed ID: 26137558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Why is the genome sequencing of meningococcus useful for us?].
    Käyhty H
    Duodecim; 2000; 116(24):2739-40. PubMed ID: 12077873
    [No Abstract]   [Full Text] [Related]  

  • 3. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Neisseria meningitidis.
    Hollingshead S; Tang CM
    Methods Mol Biol; 2019; 1969():1-16. PubMed ID: 30877666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABC of meningococcal diversity.
    Feavers IM
    Nature; 2000 Mar; 404(6777):451-2. PubMed ID: 10761900
    [No Abstract]   [Full Text] [Related]  

  • 8. The duality of virulence and transmissibility in Neisseria meningitidis.
    Taha MK; Deghmane AE; Antignac A; Zarantonelli ML; Larribe M; Alonso JM
    Trends Microbiol; 2002 Aug; 10(8):376-82. PubMed ID: 12160636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of meningococcal B vaccines.
    Prescrire Int; 2014 Sep; 23(152):204. PubMed ID: 25325114
    [No Abstract]   [Full Text] [Related]  

  • 10. Serogroup B meningococcal disease: new outbreaks, new strategies.
    Wenger JD
    JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease.
    Caugant DA
    Infect Genet Evol; 2008 Sep; 8(5):558-65. PubMed ID: 18479979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11.
    Stefanelli P; Fazio C; Vacca P; Palmieri A; Ambrosio L; Neri A; Piana A; Castiglia P; Argiolas F; Santus S; Masala L; Steri G; Riccardo F; Iannazzo S; Maraglino FP; D'Amario C; Rezza G
    Clin Microbiol Infect; 2019 Jan; 25(1):111.e1-111.e4. PubMed ID: 30036673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology. A furtive pathogen revealed.
    Nassif X
    Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward a Global Genomic Epidemiology of Meningococcal Disease.
    Retchless AC; Fox LM; Maiden MCJ; Smith V; Harrison LH; Glennie L; Harrison OB; Wang X
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S266-S273. PubMed ID: 31671445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis.
    Taha MK; Bichier E; Perrocheau A; Alonso JM
    Infect Immun; 2001 Mar; 69(3):1971-3. PubMed ID: 11179386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postgenomics of Neisseria meningitidis for vaccines development.
    Bernardini G; Braconi D; Martelli P; Santucci A
    Expert Rev Proteomics; 2007 Oct; 4(5):667-77. PubMed ID: 17941821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.
    Stephens DS
    Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B71-7. PubMed ID: 19477055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control.
    Can Fam Physician; 1994 Dec; 40():2121-3. PubMed ID: 7888825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.